Grant Awarded to Explore Hopeful New Treatment Strategies for Gastric and Esophageal Cancers March 2, 2021
Wugen Announces Exclusive License Agreement With HCW Biologics For Cell Therapies to Treat Cancer March 2, 2021
Sorrento Receives FDA Clearance to Start Clinical Trial of Anti-CD47 Antibody, Discovered from Fully Human G-MAB Library, for Treatment of Multiple Malignancies March 2, 2021
Poster on Celsion Corporation’s Phase I/II OVATION 2 Study to be Presented at the Society of Gynecologic Oncology Virtual Annual Meeting on Women’s Cancer March 2, 2021
GRAIL Announces First Health System to Offer Galleri, Novel Multi-Cancer Early Detection Blood Test March 2, 2021
Guardant360® CDx Liquid Biopsy CE-Marked for Comprehensive Tumor Mutation Profiling Across All Solid Cancers March 2, 2021
Oscotec and Beactica Therapeutics announce license and collaboration agreement to develop new cancer drug March 2, 2021
Merck Provides Update on KEYTRUDA® (pembrolizumab) Indication in Metastatic Small Cell Lung Cancer in the US March 1, 2021
HealthTree Foundation Unveils ‘Cure in Five’ Initiative for Multiple Myeloma Awareness Month March 1, 2021
AeroPress, Inc. Announces Winner of $100,000 Cookies for Kids’ Cancer Innovative Translational Research Award March 1, 2021
CytoImmune Therapeutics Establishes Operations in Puerto Rico to Develop Novel Cancer Immunotherapy Products March 1, 2021
OncoSec Announces Publication in Clinical Cancer Research of Data Supporting the Therapeutic Potential of Lead Product Candidate, TAVO™, in Triple Negative Breast Cancer March 1, 2021
Taiho Oncology Continues Support of Patient Advocacy Efforts During National Colorectal Cancer Awareness Month March 1, 2021
New NCCN Guidelines for Histiocytosis Clarify Best Practices for Recently-Defined Cancers March 1, 2021
Qualigen Therapeutics Secures Option to Negotiate License for G-Quadruplex Anti-Cancer Technology from UCL March 1, 2021
